Journal
ALLERGOLOGY INTERNATIONAL
Volume 62, Issue 3, Pages 359-365Publisher
JAPANESE SOCIETY ALLERGOLOGY
DOI: 10.2332/allergolint.12-OA-0530
Keywords
airflow limitation; airway inflammation; eosinophils; inhaled corticosteroid
Categories
Funding
- Japanese Society for the Promotion of Science and Wakayama Medical Award for Young Researchers [22591057]
- Grants-in-Aid for Scientific Research [24591136, 22591057, 24591174] Funding Source: KAKEN
Ask authors/readers for more resources
Background: Some patients with asthma have high levels of exhaled nitric oxide fraction (FENO) despite inhaled corticosteroids (ICS) therapy. Early studies suggested that this might be explained by the presence of heterogeneous airway inflammation. We aimed to assess the predictors for identifying the efficacy of systemic corticosteroids on residual FENO elevations in severe asthma. Methods: Twenty severe asthmatics with persistent FENO elevation (>= 40 ppb) despite maintenance therapy including high-daily-dose ICS were enrolled. Asthma Control Questionnaire (ACQ), lung function, blood eosinophils, and FENO were assessed before and after 14 days treatment with 0.5 mg/kg oral prednisolone/day. Results: ACQ, blood eosinophils, FENO level, FVC, FEV1, FEV1/FVC ratio and the slope of the single nitrogen washout curve (Delta N-2) were significantly improved by treatment with prednisolone. 70% of the subjects showed >= 20% reductions in the FENO levels. The reduction in FENO levels was significantly correlated with the improvements in ACQ (p < 0.0001), FVC (p < 0.01), FEV1 (p < 0.0001), and Delta N-2 (p < 0.05). Among the measurements at baseline, the FENO levels and blood eosinophil numbers were identified as significant predictors of >= 20% reductions in the FENO levels by systemic steroid therapy. Conclusions: Systemic corticosteroids could suppress the residual FENO elevations in more than half of the patients with severe asthma and the reduction in FENO levels was associated with improvements in asthma control and airflow limitation. The FENO levels and blood eosinophil numbers were the predictors of improved residual airway inflammation by systemic steroid therapy in severe asthma.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available